| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat kinase activity | 1.83e-04 | 10 | 41 | 2 | GO:0008353 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | TSC2 IGSF9B SLC24A1 KCNC3 BCR NFATC4 SIPA1L1 PCLO KIF1B ITPR3 | 1.32e-05 | 931 | 42 | 10 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | TSC2 IGSF9B SLC24A1 KCNC3 BCR NFATC4 SIPA1L1 PCLO KIF1B ITPR3 | 1.32e-05 | 931 | 42 | 10 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | TSC2 IGSF9B SLC24A1 KCNC3 BCR NFATC4 SIPA1L1 PCLO KIF1B ITPR3 | 1.42e-05 | 939 | 42 | 10 | GO:0099537 |
| GeneOntologyBiologicalProcess | cell junction organization | 1.95e-05 | 974 | 42 | 10 | GO:0034330 | |
| GeneOntologyBiologicalProcess | synaptic signaling | TSC2 IGSF9B SLC24A1 KCNC3 BCR NFATC4 SIPA1L1 PCLO KIF1B ITPR3 | 1.98e-05 | 976 | 42 | 10 | GO:0099536 |
| GeneOntologyBiologicalProcess | synapse organization | 6.17e-05 | 685 | 42 | 8 | GO:0050808 | |
| GeneOntologyCellularComponent | postsynaptic density | 2.26e-06 | 451 | 41 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 3.42e-06 | 477 | 41 | 8 | GO:0032279 | |
| GeneOntologyCellularComponent | dendrite | TSC2 SRCIN1 IGSF9B CTNND1 KCNC3 BCR SIPA1L1 PCLO KIF1B ITPR3 | 4.53e-06 | 858 | 41 | 10 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | TSC2 SRCIN1 IGSF9B CTNND1 KCNC3 BCR SIPA1L1 PCLO KIF1B ITPR3 | 4.63e-06 | 860 | 41 | 10 | GO:0097447 |
| GeneOntologyCellularComponent | postsynaptic specialization | 5.05e-06 | 503 | 41 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 6.72e-06 | 523 | 41 | 8 | GO:0098984 | |
| GeneOntologyCellularComponent | somatodendritic compartment | TSC2 SRCIN1 IGSF9B CTNND1 SLC24A1 KCNC3 BCR SIPA1L1 PCLO KIF1B ITPR3 | 1.69e-05 | 1228 | 41 | 11 | GO:0036477 |
| GeneOntologyCellularComponent | postsynapse | 2.02e-05 | 1018 | 41 | 10 | GO:0098794 | |
| GeneOntologyCellularComponent | axon | 4.57e-05 | 891 | 41 | 9 | GO:0030424 | |
| GeneOntologyCellularComponent | adherens junction | 5.70e-05 | 212 | 41 | 5 | GO:0005912 | |
| GeneOntologyCellularComponent | cyclin/CDK positive transcription elongation factor complex | 1.34e-04 | 9 | 41 | 2 | GO:0008024 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 1.60e-04 | 817 | 41 | 8 | GO:0098978 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 1.81e-04 | 56 | 41 | 3 | GO:0008023 | |
| GeneOntologyCellularComponent | neuronal cell body | 1.85e-04 | 835 | 41 | 8 | GO:0043025 | |
| GeneOntologyCellularComponent | apical junction complex | 2.56e-04 | 158 | 41 | 4 | GO:0043296 | |
| GeneOntologyCellularComponent | presynapse | 2.78e-04 | 886 | 41 | 8 | GO:0098793 | |
| GeneOntologyCellularComponent | cell body | 3.82e-04 | 929 | 41 | 8 | GO:0044297 | |
| GeneOntologyCellularComponent | anchoring junction | 5.31e-04 | 976 | 41 | 8 | GO:0070161 | |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 5.63e-04 | 18 | 41 | 2 | GO:0019908 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 9.25e-04 | 23 | 41 | 2 | GO:0098831 | |
| GeneOntologyCellularComponent | cell-cell junction | 9.64e-04 | 591 | 41 | 6 | GO:0005911 | |
| GeneOntologyCellularComponent | carboxy-terminal domain protein kinase complex | 1.01e-03 | 24 | 41 | 2 | GO:0032806 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.05e-03 | 230 | 41 | 4 | GO:0019898 | |
| GeneOntologyCellularComponent | dendritic spine | 1.27e-03 | 242 | 41 | 4 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 1.37e-03 | 247 | 41 | 4 | GO:0044309 | |
| GeneOntologyCellularComponent | distal axon | 1.54e-03 | 435 | 41 | 5 | GO:0150034 | |
| GeneOntologyCellularComponent | inhibitory synapse | 1.68e-03 | 31 | 41 | 2 | GO:0060077 | |
| GeneOntologyCellularComponent | catenin complex | 1.79e-03 | 32 | 41 | 2 | GO:0016342 | |
| GeneOntologyCellularComponent | bicellular tight junction | 2.15e-03 | 131 | 41 | 3 | GO:0005923 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 2.45e-03 | 137 | 41 | 3 | GO:0019897 | |
| GeneOntologyCellularComponent | tight junction | 2.55e-03 | 139 | 41 | 3 | GO:0070160 | |
| GeneOntologyCellularComponent | cell cortex region | 3.52e-03 | 45 | 41 | 2 | GO:0099738 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 4.06e-03 | 164 | 41 | 3 | GO:0098982 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 4.16e-03 | 49 | 41 | 2 | GO:0099092 | |
| GeneOntologyCellularComponent | cytoplasmic region | 5.30e-03 | 360 | 41 | 4 | GO:0099568 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 5.41e-03 | 56 | 41 | 2 | GO:0099091 | |
| GeneOntologyCellularComponent | organelle membrane contact site | 5.60e-03 | 57 | 41 | 2 | GO:0044232 | |
| GeneOntologyCellularComponent | cell cortex | 5.89e-03 | 371 | 41 | 4 | GO:0005938 | |
| GeneOntologyCellularComponent | cyclin-dependent protein kinase holoenzyme complex | 6.38e-03 | 61 | 41 | 2 | GO:0000307 | |
| GeneOntologyCellularComponent | axon terminus | 8.05e-03 | 210 | 41 | 3 | GO:0043679 | |
| GeneOntologyCellularComponent | nuclear speck | 9.89e-03 | 431 | 41 | 4 | GO:0016607 | |
| GeneOntologyCellularComponent | lamellipodium | 1.03e-02 | 230 | 41 | 3 | GO:0030027 | |
| GeneOntologyCellularComponent | neuron projection terminus | 1.07e-02 | 233 | 41 | 3 | GO:0044306 | |
| GeneOntologyCellularComponent | growth cone | 1.22e-02 | 245 | 41 | 3 | GO:0030426 | |
| MousePheno | midline facial cleft | 1.61e-05 | 19 | 37 | 3 | MP:0000108 | |
| MousePheno | increased vertical activity | 4.50e-05 | 250 | 37 | 6 | MP:0002574 | |
| Domain | NHS_fam | 4.94e-06 | 2 | 42 | 2 | IPR024845 | |
| Domain | NHS | 4.94e-06 | 2 | 42 | 2 | PF15273 | |
| Domain | Rap_GAP | 2.20e-04 | 10 | 42 | 2 | PF02145 | |
| Domain | Rap_GAP_dom | 2.68e-04 | 11 | 42 | 2 | IPR000331 | |
| Domain | RAPGAP | 2.68e-04 | 11 | 42 | 2 | PS50085 | |
| Domain | PDZ | 4.72e-03 | 151 | 42 | 3 | PS50106 | |
| Domain | PDZ | 4.81e-03 | 152 | 42 | 3 | IPR001478 | |
| Domain | FERM_domain | 5.43e-03 | 49 | 42 | 2 | IPR000299 | |
| Domain | FERM_1 | 5.65e-03 | 50 | 42 | 2 | PS00660 | |
| Domain | FERM_2 | 5.65e-03 | 50 | 42 | 2 | PS00661 | |
| Domain | Band_41_domain | 5.65e-03 | 50 | 42 | 2 | IPR019749 | |
| Domain | B41 | 5.65e-03 | 50 | 42 | 2 | SM00295 | |
| Domain | FERM_3 | 5.65e-03 | 50 | 42 | 2 | PS50057 | |
| Domain | Ig_2 | 1.17e-02 | 73 | 42 | 2 | PF13895 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 2.06e-10 | 218 | 42 | 8 | 33378226 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | JAK3 NHSL1 SPHK2 TSC2 SHROOM3 NUP188 BCR CDK12 CDK13 RNF43 ITPR3 | 5.50e-08 | 1105 | 42 | 11 | 35748872 |
| Pubmed | 1.92e-07 | 209 | 42 | 6 | 36779422 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 7.18e-07 | 861 | 42 | 9 | 36931259 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 24999027 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 15466011 | ||
| Pubmed | Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer. | 1.42e-06 | 2 | 42 | 2 | 35857807 | |
| Pubmed | Human CDK12 and CDK13, multi-tasking CTD kinases for the new millenium. | 1.42e-06 | 2 | 42 | 2 | 30319007 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 18343367 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 25561469 | ||
| Pubmed | CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. | 1.42e-06 | 2 | 42 | 2 | 20952539 | |
| Pubmed | 3.08e-06 | 529 | 42 | 7 | 14621295 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 38810124 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 37026485 | ||
| Pubmed | 5.95e-06 | 1431 | 42 | 10 | 37142655 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 22012619 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 27516388 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 8.62e-06 | 231 | 42 | 5 | 16452087 | |
| Pubmed | 1.00e-05 | 111 | 42 | 4 | 12508121 | ||
| Pubmed | Cyclin K-containing kinase complexes maintain self-renewal in murine embryonic stem cells. | 1.42e-05 | 5 | 42 | 2 | 22547058 | |
| Pubmed | 1.53e-05 | 446 | 42 | 6 | 24255178 | ||
| Pubmed | 1.93e-05 | 131 | 42 | 4 | 28634551 | ||
| Pubmed | Lens placode planar cell polarity is dependent on Cdc42-mediated junctional contraction inhibition. | 2.98e-05 | 7 | 42 | 2 | 26902112 | |
| Pubmed | The STAR/GSG family protein rSLM-2 regulates the selection of alternative splice sites. | 2.98e-05 | 7 | 42 | 2 | 11118435 | |
| Pubmed | 2.98e-05 | 7 | 42 | 2 | 9837810 | ||
| Pubmed | 3.97e-05 | 8 | 42 | 2 | 25038041 | ||
| Pubmed | 5.66e-05 | 1139 | 42 | 8 | 36417873 | ||
| Pubmed | 6.03e-05 | 347 | 42 | 5 | 17114649 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | 6.07e-05 | 1496 | 42 | 9 | 32877691 | |
| Pubmed | 9.32e-05 | 12 | 42 | 2 | 19884882 | ||
| Pubmed | The KIF3 motor transports N-cadherin and organizes the developing neuroepithelium. | 9.32e-05 | 12 | 42 | 2 | 15834408 | |
| Pubmed | 9.32e-05 | 12 | 42 | 2 | 12707304 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 9.96e-05 | 910 | 42 | 7 | 36736316 | |
| Pubmed | 1.06e-04 | 1247 | 42 | 8 | 27684187 | ||
| Pubmed | 1.10e-04 | 13 | 42 | 2 | 10749975 | ||
| Pubmed | Docking motif-guided mapping of the interactome of protein phosphatase-1. | 1.26e-04 | 80 | 42 | 3 | 19389623 | |
| Pubmed | 1.34e-04 | 660 | 42 | 6 | 32780723 | ||
| Pubmed | Neural defects caused by total and Wnt1-Cre mediated ablation of p120ctn in mice. | 1.48e-04 | 15 | 42 | 2 | 32741376 | |
| Pubmed | 1.62e-04 | 87 | 42 | 3 | 12465718 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 1.77e-04 | 695 | 42 | 6 | 23602568 | |
| Pubmed | Transcriptional Repression of Aerobic Glycolysis by OVOL2 in Breast Cancer. | 2.10e-04 | 95 | 42 | 3 | 35896951 | |
| Pubmed | 2.39e-04 | 1049 | 42 | 7 | 27880917 | ||
| Pubmed | 2.39e-04 | 251 | 42 | 4 | 29778605 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 3.16e-04 | 774 | 42 | 6 | 15302935 | |
| Pubmed | 3.39e-04 | 503 | 42 | 5 | 16964243 | ||
| Pubmed | 3.42e-04 | 504 | 42 | 5 | 34432599 | ||
| Pubmed | 3.43e-04 | 276 | 42 | 4 | 28319085 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 3.56e-04 | 1489 | 42 | 8 | 28611215 | |
| Pubmed | DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC. | 3.97e-04 | 118 | 42 | 3 | 37105989 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 4.17e-04 | 120 | 42 | 3 | 31413325 | |
| Pubmed | 4.70e-04 | 125 | 42 | 3 | 29467281 | ||
| Pubmed | 4.90e-04 | 27 | 42 | 2 | 19026994 | ||
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 5.51e-04 | 132 | 42 | 3 | 16944949 | |
| Pubmed | 5.63e-04 | 133 | 42 | 3 | 15144186 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 5.76e-04 | 565 | 42 | 5 | 25468996 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 7.06e-04 | 1257 | 42 | 7 | 36526897 | |
| Pubmed | 7.68e-04 | 148 | 42 | 3 | 35676246 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 8.80e-04 | 621 | 42 | 5 | 22794259 | |
| Pubmed | Generation and analysis of 280,000 human expressed sequence tags. | 1.00e-03 | 368 | 42 | 4 | 8889549 | |
| Pubmed | Transcriptional network orchestrating regional patterning of cortical progenitors. | 1.03e-03 | 39 | 42 | 2 | 34921112 | |
| Interaction | TOP3B interactions | JAK3 NHSL1 SPHK2 TSC2 SHROOM3 NUP188 BCR SRSF9 CDK12 CDK13 IMMT RNF43 KIF1B ITPR3 | 6.14e-07 | 1470 | 41 | 14 | int:TOP3B |
| Interaction | YWHAB interactions | NHSL1 NHS TSC2 SHROOM3 VIPAS39 CTNND1 BCR RNF43 RBMX SIPA1L1 KIF1B | 3.89e-06 | 1014 | 41 | 11 | int:YWHAB |
| Interaction | YWHAG interactions | NHSL1 NHS FRMD4A PPIP5K1 TSC2 SHROOM3 CTNND1 BCR MTUS1 CDK12 SIPA1L1 KIF1B | 4.44e-06 | 1248 | 41 | 12 | int:YWHAG |
| Interaction | YWHAE interactions | NHS FRMD4A TSC2 SHROOM3 SRCIN1 CTNND1 BCR CDK12 CDK13 RNF43 SIPA1L1 KIF1B | 4.74e-06 | 1256 | 41 | 12 | int:YWHAE |
| Interaction | YWHAQ interactions | NHSL1 NHS TSC2 SHROOM3 CTNND1 BCR MTUS1 NFATC4 RNF43 SIPA1L1 KIF1B | 9.87e-06 | 1118 | 41 | 11 | int:YWHAQ |
| Interaction | VASP interactions | 2.68e-05 | 294 | 41 | 6 | int:VASP | |
| Interaction | YWHAH interactions | NHSL1 NHS FRMD4A TSC2 SHROOM3 CTNND1 BCR MTUS1 SIPA1L1 KIF1B | 5.44e-05 | 1102 | 41 | 10 | int:YWHAH |
| Interaction | SFN interactions | 6.50e-05 | 692 | 41 | 8 | int:SFN | |
| Interaction | CTNNA1 interactions | 6.75e-05 | 347 | 41 | 6 | int:CTNNA1 | |
| Cytoband | 14q24.2 | 2.42e-04 | 25 | 42 | 2 | 14q24.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q24 | 8.25e-04 | 200 | 42 | 3 | chr14q24 | |
| GeneFamily | Cyclin dependent kinases | 7.88e-04 | 26 | 29 | 2 | 496 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.51e-03 | 36 | 29 | 2 | 823 | |
| GeneFamily | PDZ domain containing | 1.81e-03 | 152 | 29 | 3 | 1220 | |
| Coexpression | BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN | 1.20e-05 | 88 | 42 | 4 | M2232 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_CIRCRNA_GENES | 3.63e-05 | 40 | 42 | 3 | MM17488 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.80e-07 | 191 | 42 | 5 | 764c3a8829ae1253a0790744138266e81fc075ec | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.63e-05 | 183 | 42 | 4 | 58847e8f3a7ce3e33adba9477bcd55e769a64a90 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.74e-05 | 185 | 42 | 4 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.74e-05 | 185 | 42 | 4 | 241ea1e178fffef9e7df971de739e794332d5173 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.74e-05 | 185 | 42 | 4 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.10e-05 | 191 | 42 | 4 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.17e-05 | 192 | 42 | 4 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.17e-05 | 192 | 42 | 4 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-05 | 193 | 42 | 4 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.72e-05 | 200 | 42 | 4 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.72e-05 | 200 | 42 | 4 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.72e-05 | 200 | 42 | 4 | 75649534a98bc738fca62d071de0978dc61eb24f | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.22e-04 | 125 | 42 | 3 | a72891c3fb9cdefa9254f8e2e3c4ffa6fc3a5ffc | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.33e-04 | 127 | 42 | 3 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.49e-04 | 130 | 42 | 3 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.66e-04 | 133 | 42 | 3 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | PBMC-Mild-cDC_7|Mild / Compartment, Disease Groups and Clusters | 3.23e-04 | 142 | 42 | 3 | 58f66f35646f281e64d634e6c26adbd1d4e6c830 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Lung / Manually curated celltypes from each tissue | 3.86e-04 | 151 | 42 | 3 | 9bfb807e1180b31fa9a2c500ce993de9707c070f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.02e-04 | 153 | 42 | 3 | e7a074ea8232bacf924be78a244a8507c7e1ebc8 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-3|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.02e-04 | 153 | 42 | 3 | 9d64aadbb4bb28469af1d728457b431e21577429 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.09e-04 | 154 | 42 | 3 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.17e-04 | 155 | 42 | 3 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 4.25e-04 | 156 | 42 | 3 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-04 | 156 | 42 | 3 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-04 | 156 | 42 | 3 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.25e-04 | 156 | 42 | 3 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.49e-04 | 159 | 42 | 3 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.49e-04 | 159 | 42 | 3 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| ToppCell | Control-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 4.49e-04 | 159 | 42 | 3 | 6f50c381cd8a26a5a90bf0ce909713cea96910d7 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-04 | 161 | 42 | 3 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-04 | 161 | 42 | 3 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-04 | 161 | 42 | 3 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.66e-04 | 161 | 42 | 3 | 8de421c61f4d5a6e05fdb20e4d230e2db98ee4d5 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.75e-04 | 162 | 42 | 3 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.18e-04 | 167 | 42 | 3 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 168 | 42 | 3 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 168 | 42 | 3 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.37e-04 | 169 | 42 | 3 | c135d7ae0490d0024e0f4bd8c4ad42f6674a61da | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.46e-04 | 170 | 42 | 3 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.46e-04 | 170 | 42 | 3 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.46e-04 | 170 | 42 | 3 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 5.55e-04 | 171 | 42 | 3 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.74e-04 | 173 | 42 | 3 | 8ac2e9d39c0f76e674f8bd59d1da246bab4867c8 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.74e-04 | 173 | 42 | 3 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-04 | 174 | 42 | 3 | 6987fe7959afce347282f632abc16d800ccab7c4 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.84e-04 | 174 | 42 | 3 | 16204ff504b7b382b4d90ca35003ad5336020e07 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.84e-04 | 174 | 42 | 3 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.84e-04 | 174 | 42 | 3 | d0e3d15731de6c19c232e3aa492c39d8151cf4ed | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-04 | 175 | 42 | 3 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 6.04e-04 | 176 | 42 | 3 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-04 | 177 | 42 | 3 | fdab7b7ddfb06f913b8224c0c80574dc3cf4cbd4 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.24e-04 | 178 | 42 | 3 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 6.24e-04 | 178 | 42 | 3 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-04 | 179 | 42 | 3 | 5297f7459b40ca780a1983fecc1bb9c035c7677e | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.34e-04 | 179 | 42 | 3 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.34e-04 | 179 | 42 | 3 | f2e8fc975c30992611630197b79daaeef7c4211d | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.34e-04 | 179 | 42 | 3 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.34e-04 | 179 | 42 | 3 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.34e-04 | 179 | 42 | 3 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.45e-04 | 180 | 42 | 3 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Dendritic_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-04 | 180 | 42 | 3 | 5b7d2336ed09d07f6b8dd91c1fa9c5ade633c104 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.45e-04 | 180 | 42 | 3 | d33bb00f2b7d07dda9015cb8eafd742c2b2e9ace | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.45e-04 | 180 | 42 | 3 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.55e-04 | 181 | 42 | 3 | 153709b4dd3d81e09f251fa8765b58bed1932fda | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.55e-04 | 181 | 42 | 3 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.55e-04 | 181 | 42 | 3 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-04 | 181 | 42 | 3 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.55e-04 | 181 | 42 | 3 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.55e-04 | 181 | 42 | 3 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.55e-04 | 181 | 42 | 3 | 0c3f469bed108994ed696230e3c30343f7a301d3 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.55e-04 | 181 | 42 | 3 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.55e-04 | 181 | 42 | 3 | 6c55985e464cb0f5fb3362e9fd90351b671950f7 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.55e-04 | 181 | 42 | 3 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.66e-04 | 182 | 42 | 3 | 3d7a8d2ee2137b098248597058974ef5ae09c19e | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.66e-04 | 182 | 42 | 3 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.66e-04 | 182 | 42 | 3 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.66e-04 | 182 | 42 | 3 | d1a1feef318062f25493355d7beee8e5fb0e4206 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.76e-04 | 183 | 42 | 3 | f8b636391f752e379a5c5575fd898bdf0907a3b8 | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 6.76e-04 | 183 | 42 | 3 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.76e-04 | 183 | 42 | 3 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.76e-04 | 183 | 42 | 3 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.76e-04 | 183 | 42 | 3 | 3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-3|World / Primary Cells by Cluster | 6.87e-04 | 184 | 42 | 3 | 907ba412166bcb0526c5be0b06a76b6bd37c5a35 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.87e-04 | 184 | 42 | 3 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.87e-04 | 184 | 42 | 3 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.87e-04 | 184 | 42 | 3 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.87e-04 | 184 | 42 | 3 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.98e-04 | 185 | 42 | 3 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.98e-04 | 185 | 42 | 3 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.98e-04 | 185 | 42 | 3 | 929b68b05b7686341329ac756d7df172cb4b810b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.98e-04 | 185 | 42 | 3 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.98e-04 | 185 | 42 | 3 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-04 | 185 | 42 | 3 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.98e-04 | 185 | 42 | 3 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-04 | 185 | 42 | 3 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.09e-04 | 186 | 42 | 3 | 73cf266aeecd3cc15e8cb6094588a393bca8fbe6 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.09e-04 | 186 | 42 | 3 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.09e-04 | 186 | 42 | 3 | fef543f188edb0d1704d9c6ace366a0f8017bf53 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-04 | 186 | 42 | 3 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.09e-04 | 186 | 42 | 3 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| Computational | Neighborhood of JAK3 | 7.68e-05 | 96 | 26 | 4 | MORF_JAK3 | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.74e-05 | 193 | 42 | 5 | 4712_UP | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; HL60; HT_HG-U133A | 2.81e-05 | 194 | 42 | 5 | 2180_UP | |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; HL60; HT_HG-U133A | 2.95e-05 | 196 | 42 | 5 | 3042_UP | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.02e-05 | 197 | 42 | 5 | 4727_UP | |
| Drug | Altretamine [654-05-6]; Up 200; 19uM; HL60; HT_HG-U133A | 3.02e-05 | 197 | 42 | 5 | 3090_UP | |
| Drug | Gabapentin [60142-96-3]; Down 200; 23.4uM; HL60; HT_HG-U133A | 3.17e-05 | 199 | 42 | 5 | 2731_DN | |
| Drug | borate | 3.19e-05 | 98 | 42 | 4 | CID000007628 | |
| Drug | 23 B | 4.71e-05 | 38 | 42 | 3 | CID000011060 | |
| Drug | silicone fluid | 4.96e-05 | 6 | 42 | 2 | CID000075410 | |
| Disease | susceptibility to strep throat measurement | 1.75e-04 | 76 | 42 | 3 | EFO_0008408 | |
| Disease | hemifacial microsomia | 3.33e-04 | 19 | 42 | 2 | MONDO_0015398 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 7.84e-04 | 29 | 42 | 2 | C0496920 | |
| Disease | Ovarian Carcinoma | 8.39e-04 | 30 | 42 | 2 | C0029925 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.33e-03 | 152 | 42 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | disease progression measurement, Crohn's disease | 2.05e-03 | 47 | 42 | 2 | EFO_0000384, EFO_0008336 | |
| Disease | major depressive episode | 2.05e-03 | 47 | 42 | 2 | EFO_0007634 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.19e-03 | 181 | 42 | 3 | DOID:684 (is_implicated_in) | |
| Disease | depressive symptom measurement, stressful life event measurement | 2.32e-03 | 50 | 42 | 2 | EFO_0007006, EFO_0007781 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2.60e-03 | 53 | 42 | 2 | C1961099 | |
| Disease | interleukin 12 measurement | 2.60e-03 | 53 | 42 | 2 | EFO_0004753 | |
| Disease | hair morphology measurement | 2.70e-03 | 54 | 42 | 2 | EFO_0007821 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GRSPSPYGRRRSSSP | 321 | Q9NYV4 | |
| SSTFYNPPSGRSRSL | 276 | Q9NQ75 | |
| SSVGDASRPPYRGRS | 221 | P11274 | |
| YSRPGSESGRSTPSL | 386 | Q6H8Q1 | |
| GGSSPYSRRLPRSPS | 346 | Q14004 | |
| FGSKTRPRYSSPSLG | 46 | O94779 | |
| RPRYSSPSLGTLSAS | 51 | O94779 | |
| RDSYSSSSRGAPRGG | 361 | P38159 | |
| ARLYGRLSTRTPSPG | 676 | Q9NS39 | |
| TGGSRPGSYVLRRSP | 391 | P52333 | |
| PGSSSRYSLGPSLRR | 1836 | Q14573 | |
| TTSPGTRYGRPHSGR | 601 | P32926 | |
| APADSGRYRASPTRT | 161 | Q8IYF1 | |
| SPRGRRVGTYVPSTF | 191 | O60721 | |
| PPTGRRSGSTSSLSY | 191 | Q9ULD2 | |
| RPPGASGSALTRSFY | 61 | Q9BVV8 | |
| SPPRSLRSLFGSGYS | 1416 | O60333 | |
| PRSLSFSGPRYGRSR | 1491 | Q5SYE7 | |
| FSGPRYGRSRTPPSA | 1496 | Q5SYE7 | |
| GSRSRPSSRPSSVYG | 4286 | Q9Y6V0 | |
| PLRPCRRYSTSGSSG | 26 | Q16891 | |
| GSPDFYTPRTRSSNG | 726 | Q9P2Q2 | |
| DSSPRSFRYSIGPGN | 596 | Q6ZTQ4 | |
| DYGTARRTGTPSDPR | 301 | O60716 | |
| GYSRSRSGSRGRDSP | 191 | Q13242 | |
| VGRSRAPPAASSSRY | 1601 | Q6T4R5 | |
| RPASPCGKRRYSSSG | 261 | Q14934 | |
| RRARPPDSSGSGESY | 436 | Q68DV7 | |
| SSSGPRSFYPRQGAT | 1466 | O43166 | |
| SYPRPEGRTGASASF | 721 | Q8TF72 | |
| GGSPRSSARRYSGRA | 316 | Q8IXZ3 | |
| AGRYPGARTASGTRP | 16 | Q9UBN6 | |
| GSYPARGPRFALTLT | 56 | Q9NRA0 | |
| SRSRLSYAGGRPPSY | 326 | Q9C0H9 | |
| SSRSGSPSYRPAMGF | 1261 | Q9UPX0 | |
| YRRPRFLRGSSSSPG | 31 | Q96MI6 | |
| SSLSRYFRRGAPSSP | 1696 | Q5SRE5 | |
| YFRRGAPSSPATGVL | 1701 | Q5SRE5 | |
| GALYGRRPRSTFPNS | 196 | Q9P0W8 | |
| TYSLSSFFRGRTRPG | 106 | Q9H9C1 | |
| GTRTYNPPTDFSGLR | 361 | Q9HBF4 | |
| SSRPGGYRLFSSSRP | 996 | Q6PFW1 | |
| PSSRARGPASSGRKY | 66 | C9JLR9 | |
| RSPSGLRPRGYTISD | 1451 | P49815 | |
| SPITPGSRGRYSRDR | 691 | Q14003 |